Reactions 1479, p23 - 23 Nov 2013

Maraviroc

Skin rash: case reportFrom a study, an adult [age and sex not stated] was identified

after developing skin rash while receiving maraviroc.The patient was receiving maraviroc [dosage and route not

stated], as well as ritonavir-boosted darunavir therapy, for HIV-I infection. The patient subsequently developed a skin rash[duration of treatment to reaction onset not stated], andmaraviroc was withdrawn [outcome not stated].

Author comment: "Only 1 of our cohort whodiscontinued maraviroc did so because of an adverse drugreaction, that is rash."Babiker ZOE, et al. Real-life outcomes of Maraviroc-based regimens inHIV-1-infected individuals. Journal of the International Association of Providers ofAIDS Care 12: 12-14, No. 1, Feb 2013. Available from: URL: http://dx.doi.org/10.1177/1545109712462454 - United Kingdom 803096012

1

Reactions 23 Nov 2013 No. 14790114-9954/13/1479-0001/$14.95 Adis © 2013 Springer International Publishing AG. All rights reserved